HIPRA launches ICTHIOVAC® VR/PD (vaccine against vibriosis and pasteurellosis in sea bass) in Spain, Italy, Portugal, France and Tunisia

Filtered by {{cFt}} Back to news
Home News HIPRA launches ICTHIOVAC® VR/PD (vaccine against vibriosis and pasteurellosis in sea bass) in Spain, Italy, Portugal, France and Tunisia

HIPRA launches ICTHIOVAC® VR/PD (vaccine against vibriosis and pasteurellosis in sea bass) in Spain, Italy, Portugal, France and Tunisia


On 6th June in Malta, HIPRA introduced its new injectable vaccine against vibriosis and pasteurellosis in sea bass, ICTHIOVAC® VR/PD. The main producers of sea bream and sea bass in Spain, Italy, Portugal, France and Tunisia, as well various veterinarians associated with Mediterranean aquaculture, were present at the event.


Prevention of vibriosis and pasteurellosis in sea bass by means of intraperitoneal injection has become essential because of the high prevalence of these two classic pathologies owing to factors such as natural reservoirs in wild species or intensification of cultivation.

ICTHIOVAC® VR/PD contains 4 different antigens (P. damselae subs. piscicida, L. anguillarum serotype O1, L. anguillarum serotype O2a, L. anguillarum serotype O2b), thereby conferring comprehensive protection against vibriosis and pasteurellosis.

Adjuvanted with AQUAMUN, HIPRA’s adjuvant for aquaculture, ICTHIOVAC® VR/PD maintains a perfect balance between inflammatory reaction and minimizing internal damage.

The guests were welcomed by Javier Sanz (Marketing Director at HIPRA), who presented the company, as well as setting out its distinctive characteristics of quality and innovation and its focus on and commitment to prevention in animal health.

Dr. Francesc Padrós of the fish pathology diagnostic service of the Autonomous University of Barcelona then presented “Vibriosis and Pasteurellosis, the classic duo in Mediterranean aquaculture” addressing the different characteristics of the two pathologies and the importance of prevention.

Following this contribution, Agnès Callol (Researcher and Project Manager in HIPRA’s Biological R + D Department) presented the trials carried out during the development of the vaccine in terms of the safety and efficacy.

To conclude the session, Gustavo Espelleta (Brand Manager at HIPRA) spoke of the importance of vaccination in aquaculture from a practical perspective and the important aspects that need to be taken into account during the planning, performance and monitoring of vaccination in fish.

Following the technical sessions, all the participants enjoyed a dinner in the Xara Lodge, an ancient XVIIth century palace. With this new launch, HIPRA reaffirms its commitment to prevention in Animal Health and to Aquaculture in particular.

Share this on